These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4450338)

  • 1. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Trans Am Soc Artif Intern Organs; 1974; 20A():197-202. PubMed ID: 4450338
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
    Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteopenia and fractures occurring during maintenance hemodialysis. A new form of renal osteodystrophy.
    Parfitt AM; Massry SG; Winfield AC
    Clin Orthop Relat Res; 1972 Sep; 87():287-302. PubMed ID: 5078040
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone disease in patients dialyzed with untreated water.
    Rashid A; Posen GA; Gray D; Jaworski ZF
    Med Instrum; 1974; 8(3):204-6. PubMed ID: 4838450
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 6. Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes.
    Parfitt AM; Massry SG; Winfield AC; DePalma JR; Gordon A
    Am J Med; 1971 Sep; 51(3):319-30. PubMed ID: 5115990
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoride metabolism in uremia.
    Nielsen E; Solomon N; Goodwin NJ; Siddhivarn N; Galonsky R; Taves D; Friedman EA
    Trans Am Soc Artif Intern Organs; 1973; 19():450-5. PubMed ID: 4722761
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dialysate calcium and fluoride on bone disease during regular hemodialysis.
    Jowsey J; Johnson WJ; Taves DR; Kelly PJ
    J Lab Clin Med; 1972 Feb; 79(2):204-14. PubMed ID: 5009710
    [No Abstract]   [Full Text] [Related]  

  • 10. Dialysis bone disease. A quantitative histologic study.
    Binswanger U; Sherrard D; Rich C; Curtis FK
    Nephron; 1974; 12(1):1-9. PubMed ID: 4838006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium metabolism in chronic uraemia and in patients on chronic intermittent haemodialysis (author's transl)].
    Skrabal F; Dittrich P
    Wien Klin Wochenschr; 1974 Apr; 86(7):169-77. PubMed ID: 4207089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of binephrectomy on osteodystrophy due to chronic hemodialysis].
    Fournier A; Tunchott S; Bedrossian J; Idatte JM; Bordier P
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1001-3. PubMed ID: 4661184
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoride metabolism and renal osteodystrophy in regular dialysis treatment.
    Erben J; Hájaková B; Pantůcek M; Kubes L
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():421-5. PubMed ID: 3991535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of body composition by neutron activation analysis in patient with renal failure.
    Cohn SH; Cinque TJ; Dombrowski CS; Letteri JM
    J Lab Clin Med; 1972 Jun; 79(6):978-94. PubMed ID: 4623613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of aluminum gels on renal osteodystrophy caused by chronic hemodialysis. Increase in the total surface of osseous resorption in anephric patients].
    Fournier A; Tunchot S; Bedrossians J; Idatte JM; Bordier P
    Sem Hop; 1974 Nov; 50(45):2803-10. PubMed ID: 4375854
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of phosphate binging agents on bone remodelling in patients on regular haemodialysis.
    Fournier A; Tunchot S; Bedrossian J; Sionest JG; Idatte JM; Bordier P
    Proc Eur Dial Transplant Assoc; 1972; 9():126-41. PubMed ID: 4668905
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of dialysis treatment and kidney transplantation on the behavior of bone and small intestine alkaline phosphatase isoenzymes with reference to blood groups and secondary hyperparathyroidism].
    Koall W; Mampel E; Luci V; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Nov; 37(22):745-52. PubMed ID: 6764064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between bone fluorides and renal osteodystrophy in chronic renal insufficiency].
    Hájková B; Erben J; Kubes L; Pantůcek M
    Vnitr Lek; 1985 Sep; 31(9):852-7. PubMed ID: 4049761
    [No Abstract]   [Full Text] [Related]  

  • 20. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.